Exact Mass: 691.3053

Exact Mass Matches: 691.3053

Found 11 metabolites which its exact mass value is equals to given mass value 691.3053, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Noa-Asn-Apns-Dmt-NH-tBu

N-[4-[4-(tert-butylcarbamoyl)-5,5-dimethyl-1,3-thiazolidin-3-yl]-3-hydroxy-4-oxo-1-phenylbutan-2-yl]-2-[(2-naphthalen-1-yloxyacetyl)amino]butanediamide

C36H45N5O7S (691.304)


   
   

3beta-O-propionyl-5alpha-O-benzoyl-7beta-O-acetyl-17-O-nicotinoylpremyrsinol|euphorbialoid A

3beta-O-propionyl-5alpha-O-benzoyl-7beta-O-acetyl-17-O-nicotinoylpremyrsinol|euphorbialoid A

C38H45NO11 (691.2992)


   

(3S)-3-methylsulfanyl-1-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-N-[3-(6-propan-2-yloxypyridin-3-yl)-1H-indazol-5-yl]pyrrolidine-3-carboxamide

(3S)-3-methylsulfanyl-1-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-N-[3-(6-propan-2-yloxypyridin-3-yl)-1H-indazol-5-yl]pyrrolidine-3-carboxamide

C37H41N9O3S (691.3053)


MK-8353 (SCH900353) is a potent, selective and orally available ERK1/2 inhibitor, with IC50s of 23.0 nM and 8.8 nM, respectively; MK-8353 has antitumor activity.

   
   
   
   

[(1r,2r,3r,4s,5s,7r,9s,10r,11s,13s,15r)-15-(acetyloxy)-2-(benzoyloxy)-7,9-dihydroxy-5,9,12,12-tetramethyl-8-oxo-4-(propanoyloxy)tetracyclo[8.5.0.0³,⁷.0¹¹,¹³]pentadecan-1-yl]methyl pyridine-3-carboxylate

[(1r,2r,3r,4s,5s,7r,9s,10r,11s,13s,15r)-15-(acetyloxy)-2-(benzoyloxy)-7,9-dihydroxy-5,9,12,12-tetramethyl-8-oxo-4-(propanoyloxy)tetracyclo[8.5.0.0³,⁷.0¹¹,¹³]pentadecan-1-yl]methyl pyridine-3-carboxylate

C38H45NO11 (691.2992)


   

5-benzyl-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

5-benzyl-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

C36H45N5O7S (691.304)


   

(2s,5s,8s,11s,14r,15r)-5-benzyl-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

(2s,5s,8s,11s,14r,15r)-5-benzyl-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

C36H45N5O7S (691.304)


   

(2s,5s,11s,14r,15r)-5-benzyl-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

(2s,5s,11s,14r,15r)-5-benzyl-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

C36H45N5O7S (691.304)